Skip to main content

Royals DFA of former Brewer Nick Mears gives more context to year-old trade

Neither side is happy with their return one year after the trade went down.
ByTyler Koerth
May 27, 2026; Kansas City, Missouri, USA; Kansas City Royals pitcher Nick Mears (31) returns to the dugout against the New York Yankees during the game at Kauffman Stadium. Mandatory Credit: Denny Medley-Imagn Images
May 27, 2026; Kansas City, Missouri, USA; Kansas City Royals pitcher Nick Mears (31) returns to the dugout against the New York Yankees during the game at Kauffman Stadium. Mandatory Credit: Denny Medley-Imagn Images | IMAGN IMAGES via Reuters Connect

Around this time last year, the Milwaukee Brewers and Kansas City Royals came together for a somewhat surprising trade. Fresh off breakout 2025 campaigns during which Nick Mears recorded a 3.49 ERA and posted three scoreless postseason appearances, and outfielder Isaac Collins finished fourth in rookie of the year voting, Matt Arnold dealt both players to the Royals for left-hander Angel Zerpa, who posted a 4.18 ERA that same year.

On paper, the Royals certainly appeared to get the better end of the deal initially, though some saw it as a sell-high, buy-low deal from the Brewers' side. However, just one year later, the trade looks like a lose-lose for both sides. Mears managed to appear in only 21 games before undergoing surgery for thoracic outlet syndrome, Collins saw his production plummet from a 2.6 fWAR season in Milwaukee to just 0.1 fWAR in Kansas City, and Zerpa suffered an elbow injury that required Tommy John surgery in mid-May.

Adding further context to the three-player swap, is the fact that the Royals designated Mears for assignment ahead of tonight's non-tender deadline, which takes effect at 4:00 p.m. CT. Interestingly, that same move is also something Milwaukee may be contemplating with Zerpa as well.

Brewers and Royals' year-old, three-player swap now looks like a lose-lose trade with non-tender deadline approaching

As mentioned, Mears underwent surgery for thoracic outlet syndrome during the 2026 season, but not until August. With his recovery timeline still uncertain, Kansas City opted against tendering him a contract projected to be worth $2.2 million, designating him for assignment instead.

Zerpa, meanwhile, underwent Tommy John surgery in mid-May. Given his role as a reliever, a return sometime late in the first half of 2027 isn't out of the question, but that is provided his recovery goes without any setbacks. More likely, he won't be at full strength until the final months of the 2027 season. Therefore, despite an estimated salary of just $1.3 million, it wouldn't be surprising to see Milwaukee non-tender him. Doing so would free up another spot on the 40-man roster after the Brewers recently used all six of their previously available spots to protect prospects ahead of the Rule 5 Draft protection deadline. Additionally, non-tendering Zerpa does not prevent the Brewers from bringing the southpaw back on a minor league deal or a modified major league contract.

It's crazy what a difference a year can make, and unfortunate that said difference was caused by injuries for both Zerpa and Mears. One year ago, when this Brewers-Royals trade went down, it looked like both sides were filling obvious needs, and all three players involved would have important roles in 2026. Now, that win-win forecast has become a lose-lose outcome, serving as a reminder of how quickly the evaluation of a trade can change in MLB.

Add us as a preferred source on Google